No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / secondary
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Female
-
Follow-Up Studies
-
Gemcitabine
-
Hemolytic-Uremic Syndrome / chemically induced*
-
Hemolytic-Uremic Syndrome / therapy
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Immunosuppressive Agents / therapeutic use
-
Middle Aged
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / pathology
-
Plasmapheresis
-
Ribonucleotide Reductases / antagonists & inhibitors
Substances
-
Immunosuppressive Agents
-
Deoxycytidine
-
Ribonucleotide Reductases
-
Gemcitabine